Technology: Regenerative Medicine, Stem cell therapy
Industry: Cell Therapy, Public
Headquarters: Tokyo, Tokyo, Japan
Founded Date: 2013-02-27
Employees Number: 51-100
Funding Status: IPO
Investors Number: 6
Total Funding: 48289182
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-01-01
Last Funding Type: Post-IPO Equity

Visit Website
info@san-bio.com
Register and Claim Ownership